AB053. P-21. M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): efficacy by BTC subtype

BACKGROUND: Biliary tract cancers (BTCs) are a group of cancers with poor prognosis and few treatment options. For 2L chemotherapy, no standard-of-care therapy exists, and overall response rates ORRs) are <10%. M7824 is an innovative first-in-class bifunctional fusion protein composed of 2 extrac...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hepatobiliary Surg Nutr
Glavni autori: Yoo, Changhoon, Oh, Do-Youn, Choi, Hye Jin, Kudo, Masatoshi, Ueno, Makoto, Kondo, Shunsuke, Chen, Li-Tzong, Osada, Motonobu, Helwig, Christoph, Dussault, Isabelle, Ikeda, Masafumi
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Poster Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421177/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB053
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items